Weiss Ratings Reiterates Hold (C) Rating for U.S. Physical Therapy (NYSE:USPH)

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “hold (c)” rating reaffirmed by equities research analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Several other research analysts have also weighed in on USPH. Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. Barrington Research increased their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a report on Friday, August 8th. JPMorgan Chase & Co. started coverage on shares of U.S. Physical Therapy in a report on Thursday, September 18th. They set an “overweight” rating and a $110.00 price objective on the stock. Finally, Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

U.S. Physical Therapy Price Performance

NYSE:USPH opened at $89.15 on Wednesday. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 38.93, a price-to-earnings-growth ratio of 4.53 and a beta of 1.48. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The company’s 50-day moving average is $83.27 and its two-hundred day moving average is $77.25. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. The company had revenue of $197.34 million for the quarter, compared to analyst estimates of $190.24 million. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 EPS. Research analysts expect that U.S. Physical Therapy will post 2.67 EPS for the current year.

Insider Buying and Selling

In other U.S. Physical Therapy news, COO Eric Joseph Williams sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $85.25, for a total value of $85,250.00. Following the completion of the sale, the chief operating officer owned 25,331 shares of the company’s stock, valued at $2,159,467.75. This trade represents a 3.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nancy Ham sold 600 shares of the stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total transaction of $49,026.00. Following the completion of the sale, the director directly owned 1,994 shares of the company’s stock, valued at $162,929.74. This trade represents a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,853 shares of company stock valued at $581,406 over the last three months. Company insiders own 2.00% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

Several large investors have recently bought and sold shares of USPH. Nuveen LLC acquired a new stake in shares of U.S. Physical Therapy during the first quarter worth approximately $8,702,000. Bahl & Gaynor Inc. grew its position in shares of U.S. Physical Therapy by 32.6% during the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock worth $24,964,000 after buying an additional 84,878 shares in the last quarter. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 8.9% during the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock worth $69,499,000 after buying an additional 72,463 shares in the last quarter. Woodline Partners LP grew its position in shares of U.S. Physical Therapy by 228.0% during the first quarter. Woodline Partners LP now owns 82,419 shares of the company’s stock worth $5,964,000 after buying an additional 57,293 shares in the last quarter. Finally, Jane Street Group LLC grew its position in shares of U.S. Physical Therapy by 249.3% during the first quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after buying an additional 35,191 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.